Dr. Jose Miguel Rivera-Caravaca, from the Hospital Clínico Universitario Virgen de la Arrixaca Instituto Murciano de Investigación Biosanitaria, in Murcia, Spain, shares results of his study appearing in the August 2018 issue of Mayo Clinic Proceedings, comparing results between a randomized controlled trial and real world outcomes for patients taking anti-coagulation therapy. Because of many factors eliminated from controlled trials, his results showed higher incidents of adverse outcomes. Available at: [ Ссылка ]
